J. Marc Simard
Director/Board Member at Remedy Pharmaceuticals, Inc.
Profile
Dr. J.
M.
Simard is on the Board of Directors at Remedy Pharmaceuticals, Inc.
Dr. Simard was previously employed as an Advisory Board Member by Carrot Capital LLC.
He received his undergraduate degree from St. Anselm College and a doctorate degree from Creighton University.
J. Marc Simard active positions
| Companies | Position | Start |
|---|---|---|
Remedy Pharmaceuticals, Inc.
 Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Director/Board Member | - |
Former positions of J. Marc Simard
| Companies | Position | End |
|---|---|---|
Embark Healthcare
 Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Training of J. Marc Simard
| St. Anselm College | Undergraduate Degree |
| Creighton University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Embark Healthcare
Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- J. Marc Simard
